• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 37 of 100
Moderna coronavirus vaccine trial
HealthModerna releases promising—but early—new coronavirus vaccine data
By Sy MukherjeeMay 18, 2020
ZOE.07.20.Kristin-Peck
MagazineThe CEO who keeps animal pharm growing
By Anne SradersMay 16, 2020
Antibody testing will be key—once we understand what the results mean
HealthAntibody testing will be key—once we understand what the results mean
By Sy MukherjeeMay 12, 2020
Gilead remdesivir price
NewslettersGilead’s moral (and financial) COVID-19 conundrum
By Sy MukherjeeMay 7, 2020
Gilead-Sciences-Remdesivir
HealthRemdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By Sy MukherjeeMay 1, 2020
COVID forgotten communities
NewslettersThe communities we forget during COVID-19
By Sy MukherjeeApril 30, 2020
Gilead remdesivir coronavirus FDA
HealthGilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step
By Sy MukherjeeApril 30, 2020
The coronavirus pandemic is impacting critical research into neuromuscular diseases
HealthThe coronavirus pandemic is impacting critical research into neuromuscular diseases
By Sy MukherjeeApril 28, 2020
People observing social distancing rules while waiting in line outside a Walgreens Pharmacy in New York City.
TechHow a pharmacy delivery startup has capitalized on the coronavirus pandemic
By Jeremy KahnApril 21, 2020
Big Pharma has the chance to come to the world’s rescue
MagazineBig Pharma has the chance to come to the world’s rescue
By Sy MukherjeeApril 20, 2020
A pharmacist counts prescription drugs at the at the CentreTown Pharmacy.
CommentaryPrescription drug costs are spiraling, but price controls are the wrong solution
By Karen KerriganApril 18, 2020
The key problem to solve in the quest for coronavirus treatments
NewslettersThe key problem to solve in the quest for coronavirus treatments
By Sy MukherjeeApril 9, 2020
How the best workplaces in health care and biopharma are responding to COVID-19
HealthHow the best workplaces in health care and biopharma are responding to COVID-19
By Ed FrauenheimApril 9, 2020
A researcher works on virus replication in order to develop a vaccine against the coronavirus COVID-19, in Belo Horizonte, state of Minas Gerais, Brazil, on March 26, 2020. - The Ministry of Health convened The Technological Vaccine Center of the Federal University of Minas Gerais laboratory to conduct research on the coronavirus COVID-19 in order to diagnose, test and develop a vaccine. (Photo by Douglas MAGNO / AFP) (Photo by DOUGLAS MAGNO/AFP via Getty Images)
CommentaryThese pharmaceutical companies are the top inventors and innovators
By IDEA PharmaApril 6, 2020
Johnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
HealthJohnson & Johnson hopes to have its promising coronavirus vaccine approved by early 2021
By Sy MukherjeeMarch 30, 2020
1...
  • 35
  • 36
  • 37
  • 38
  • 39
...100
Most Popular
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Sydney LakeJune 13, 2026
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Economy
Boomers actually do hold most of the wealth and power. So why do they call it 'whiny' to point that out?placeholder alt text
By Nick LichtenbergJune 14, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.